Where GHK-Cu is sold as a powder that is reconstituted for injection, a typical starting dose is 1mg per day over a treatment course
Depending on the severity and location, a stable horizontal tear may heal without surgery
BPC-157 has been studied across gastrointestinal, musculoskeletal, cardiovascular, and neurological models reflecting proposed interactions with multiple signalling systems including the NO pathway, growth factor receptors, and neurotransmitter systems
Scientific Overview: BPC-157 is a synthetic pentadecapeptide composed of 15 amino acids, originally derived from human gastric juice protein known for its unique biochemical properties
GHK-Cus primary contraindication involves copper metabolism disorders, particularly Wilsons Disease, where copper accumulation causes organ damage
In laboratory settings it functions as a carrier medium whose buffering-neutral, low-ionic composition facilitates dissolution of peptide and small-molecule powders for in vitro and model-system handling
